[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 52.200.130.163. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1988

Wound Prophylaxis With Metronidazole in Head and Neck Surgical Oncology

Arch Otolaryngol Head Neck Surg. 1988;114(10):1083. doi:10.1001/archotol.1988.01860220017001

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

At the January 1988 meeting of the Western Section of the Triological Society, Robbins and collaborators from the University of Texas–M. D. Anderson Hospital, Houston, reported their results of a prospective randomized study of patients undergoing head and neck oncologic surgical procedures. The patients were divided in two groups: group A received cefazolin, 1000 mg intravenously (IV) one hour preoperatively and 500 mg every eight hours for a total of six doses, and metronidazole (Flagyl), 500 mg IV one hour preoperatively and 250 mg IV every eight hours postoperatively for six doses. Group B received cefazolin alone in the same dosage and regimen.

The rate of wound infection in group A (158 patients) was 9.5% compared with 18.6% in group B (172 patients) (P =.03). Patients undergoing clean procedures had a 4.9% infection rate compared with clean-contaminated and contaminated procedures, which had a higher infection rate of 3.5-fold and 6.5-fold,

First Page Preview View Large
First page PDF preview
First page PDF preview
×